Saturday 17 October 2026 Export EBS’s income statement to Excel — free account

Emergent Biosolutions Inc.

EBS Healthcare Drug Manufacturers Specialty & Generic

Emergent Biosolutions Inc.’s revenue for fiscal 2025 (year ended December 2025) was $742.9 million, down 28.8% from fiscal 2024. In the quarter to June 2026, revenue grew 66.3%, EPS fell 1,486.4%, free cash flow fell 47.7% and total debt fell 12.9%, each against the same quarter a year earlier.

6.38 0.80 −11.14%

Follow EBS

Alert me

Market cap: $368.1M
P/E: 0.0×
Fwd P/E: −26.5×
Dividend yield: —
F-score: 6/9
Altman Z: 1.63
Beneish M: −3.56
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(40.29%)	(1.60%)	10.46%	13.92%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	5	5	6	5
ROA Full definition →	(13.95%)	(0.63%)	3.88%	5.17%
ROIC Full definition →	(5.27%)	4.06%	7.06%	7.43%
Return on Tangible Assets Full definition →	(24.51%)	(1.25%)	7.15%	8.82%
Average Days of Receivables Full definition →	90.04	65.58	41.37	69.17
Free Cash Flow per Share Full definition →	1.67	2.61	3.64	0.75
Free Cash Flow Full definition →	86.10	135.50	195.00	39.90
Capital Expenditures Full definition →	(11.60)	(12.50)	24.40	26.90
Other line items
Cash ROIC Full definition →	8.09%	10.77%	14.96%	2.67%
Accounts Receivable Turnover Full definition →	5.71	4.16	6.22	5.83
Accounts Payable Turnover Full definition →	5.97	6.35	5.60	5.15
Inventory Turnover Full definition →	1.06	0.97	1.00	1.06
Average Days of Payables Full definition →	53.91	46.55	62.21	58.31
Days of Inventory on Hand Full definition →	326.02	386.10	384.25	361.95
Tax Rate Full definition →	0.21	(3.46)	(0.36)	(0.28)
Research and Development Expense of Revenue Full definition →	5.88%	7.18%	7.16%	6.36%
Selling, General and Administrative Expense of Revenue Full definition →	23.53%	26.64%	25.05%	24.82%
Share Based Compensation of Revenue Full definition →	2.45%	2.45%	2.18%	1.93%
Interest Coverage Full definition →	(1.30)	1.09	1.69	2.00
Operating CF/Net income Full definition →	(0.55)	(17.21)	3.24	0.17
Depreciation/Fixed assets Full definition →	0.58	0.52	0.51	0.51
Capex/Depreciation Full definition →	(0.11)	(0.12)	0.23	0.25
Revenue per Share Full definition →	14.93	13.04	13.89	14.83
Operating CF per Share Full definition →	1.89	2.85	3.19	0.24
Capex per Share Full definition →	(0.22)	(0.24)	0.46	0.51
Capex to Sales Full definition →	0.02	0.02	(0.03)	(0.03)

Show all line items

Columns are period end dates

Stockrow Weekly